What is the active ingredient in Acetylsalicylsäure (ASS)?
Acetylsalicylsäure
It is a thrombozytenaggregationshemmer and inhibits Cyclooxygenase.
What is the concentration of Acetylsalicylsäure (ASS) in the medication?
500 mg Trockensubstanz + 5 ml Lösungsmittel
This indicates the amount of active substance and solvent in the formulation.
List the indications for Acetylsalicylsäure (ASS).
- akutes Koronarsyndrom
- Myokardinfarkt
These conditions require careful consideration of benefits and risks before administration.
What are the contraindications for using Acetylsalicylsäure (ASS)?
- Überempfindlichkeit gegen den Wirkstoff oder Salicylate
- aktuelle innere Blutung
- Trauma mit Gefahr einer nicht komprimierbaren Blutung
- akutes Aortensyndrom
- Blutungsneigung/ hämorrhagische Diathese
- letztes Trimenon der Schwangerschaft
- Überempfindlichkeit gegen andere NSAR
- Asthmaanfall
- aktuelles Ulcus ventriculi oder Ulcus duodeni
- schwere Leber- und Nierenfunktionsstörungen
- schwerer Glucose-6-Phosphat-Dehydrogenasemangel
- Methotrexat-Einnahme
- Altersbegrenzung: keine Anwendung durch NotSan bei Pat. <18 Jahren
These conditions indicate that the medication should not be used due to potential risks.
What is the onset of action for Acetylsalicylsäure (ASS)?
nach 10 - 15 min
This is the time it takes for the medication to start working after administration.
What is the duration of action for Acetylsalicylsäure (ASS)?
Tage (Lebensdauer der Thrombozyten)
The effect lasts for several days, corresponding to the lifespan of platelets.
What are some adverse effects associated with Acetylsalicylsäure (ASS)?
- Bronchospasmus
- Auslösung eines Asthmaanfalls
- Blutungsgefahr
- gastrointestinalen Beschwerden (Übelkeit, Erbrechen)
These effects highlight the risks involved in using the medication.
What is the dosage for intravenous administration of Acetylsalicylsäure (ASS)?
250 mg langsam iv.
This specifies the recommended intravenous dosage for administration.
What is the oral dosage for Acetylsalicylsäure (ASS)?
200 mg
This indicates the recommended oral dosage for administration.
When is the next planned revision for the guidelines regarding Acetylsalicylsäure (ASS)?
Juli 2027
This indicates when the guidelines will be reviewed and potentially updated.
